BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/30/2024 7:39:33 AM | Browse: 64 | Download: 242
 |
Received |
|
2024-03-12 08:19 |
|
Peer-Review Started |
|
2024-03-12 08:19 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2024-04-24 09:11 |
|
Revised |
|
2024-04-29 08:17 |
|
Second Decision |
|
2024-05-23 02:41 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2024-05-23 05:54 |
|
Articles in Press |
|
2024-05-23 05:54 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-06-11 04:02 |
|
Publish the Manuscript Online |
|
2024-06-30 07:39 |
| ISSN |
1948-9366 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: Https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Randomized Controlled Trial |
| Article Title |
Radiofrequency ablation combined with transcatheter arterial chemoembolization for recurrent liver cancer
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Jin-You Guo, Li-Li Zhao, Hui-Jun Cai, Hui Zeng and Wei-Dong Mei |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Wei-Dong Mei, BM BCh, Attending Doctor, Department of Oncology, The Second People's Hospital of Zhejiang Province Taizhou Yuhuan City, No. 77 Environmental Protection Middle Road, Chumen Town, Yuhuan City, Taizhou 317605, Zhejiang Province, China. mwd20240204@163.com |
| Key Words |
Transcatheter arterial chemoembolization; Radiofrequency ablation; Recurrent liver cancer; Clinical efficacy; Overall response rate; Disease control rate |
| Core Tip |
The postoperative recurrence rate of liver cancer is high. Although radiofrequency ablation (RFA) combined with transcatheter arterial chemoembolization (TACE) is an effective treatment for liver cancer, its efficacy in recurrent liver cancer remains unclear. Results of the present study revealed that TACE combined with RFA was effective for the treatment of recurrent liver cancer and could significantly reduce alpha-fetoprotein levels and improve various indices of liver function. |
| Publish Date |
2024-06-30 07:39 |
| Citation |
<p>Guo JY, Zhao LL, Cai HJ, Zeng H, Mei WD. Radiofrequency ablation combined with transcatheter arterial chemoembolization for recurrent liver cancer. <i>World J Gastrointest Surg</i> 2024; 16(6): 1756-1764</p> |
| URL |
https://www.wjgnet.com/1948-9366/full/v16/i6/1756.htm |
| DOI |
https://dx.doi.org/10.4240/wjgs.v16.i6.1756 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
